Anzeige
Mehr »
Login
Dienstag, 11.02.2025 Börsentäglich über 12.000 News von 685 internationalen Medien
US-Biotech-Firma sorgt für Furore - steckt hier die Zukunft der Krebsheilung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QEVG | ISIN: CA8031604074 | Ticker-Symbol: 48S1
Frankfurt
11.02.25
08:03 Uhr
0,007 Euro
+0,002
+40,00 %
Branche
Rohstoffe
Aktienmarkt
Sonstige
1-Jahres-Chart
SARAMA RESOURCES LTD Chart 1 Jahr
5-Tage-Chart
SARAMA RESOURCES LTD 5-Tage-Chart
RealtimeGeldBriefZeit
0,0080,02619:22
ACCESS Newswire
92 Leser
Artikel bewerten:
(0)

Sarama Resources Ltd.: Sarama Completes Tranche 2 Options Placement

Finanznachrichten News

NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES

VANCOUVER, BC AND PERTH, AUSTRALIA / ACCESS Newswire / February 11, 2025 / Sarama Resources Ltd. ("Sarama" or the "Company") (ASX:SRR)(TSX-V:SWA) is pleased to report that on 11 February 2025, it completed the final tranche of the previously announced A$2m equity placement (the "Placement") (refer to Sarama's news releases dated 21 November 2024 and 29 November 2024).

The second and final tranche of the Placement ("Tranche 2") consisted of 16,666,666 free attaching unlisted options (each a "Placement Option") and 14,000,000 broker options (each a "Broker Option" and together with the Placement Options, the "Options"), with each Option exercisable at A$0.09 and expiring on 30 November 2028. The issuance of the Tranche 2 Options was subject to shareholder approval which was obtained at the special meeting held on 4 February 2025 (the "Meeting").

The first tranche of the Placement, completed on 29 November 2024, raised aggregate gross proceeds of A$2,000,000 with the Company issuing 66,666,666 CDIs at an issue price of A$0.03 per CDI.

Tranche 2 of the Placement was issued to institutional and other sophisticated and professional investors upon receipt of shareholder approval, as required by the ASX Listing Rules, at the Meeting. An Appendix 3G was announced to the Australian Stock Exchange ("ASX") on 11 February 2025 and provides further detail on the issue of Tranche 2.

Members of Sarama's Board and Management have not subscribed for any CDIs in the Placement.

Funds raised from the Placement will be used for exploration activities, general working capital purposes and for general and administration costs. None of the proceeds from the Placement will be used for payments to non-arm's length parties or persons conducting investor relations activities.

No Finders' fees were paid in connection with Tranche 2 of the Placement. The Placement remains subject to the final approval of the TSX Venture Exchange ("TSXV"). The CDIs issued under the Placement are not subject to any hold periods as all subscribers under the Placement were located outside of Canada.

This announcement was authorised by the Board of Sarama.

Neither the TSXV nor its Regulation Services Provider (as that term is defined in policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

For further information, please contact:

Andrew Dinning
Sarama Resources Ltd

e: info@saramaresources.com
t: +61 8 9363 7600

CAUTION REGARDING FORWARD LOOKING INFORMATION

Information in this news release that is not a statement of historical fact constitutes forward-looking information. Such forward-looking information includes, but is not limited to, statements regarding the intended use of proceeds from the Placement and receiving the approval of the TSXV. Actual results, performance or achievements of the Company may vary from the results suggested by such forward-looking statements due to known and unknown risks, uncertainties, and other factors. Such factors include, among others, that the business of exploration for gold and other precious minerals involves a high degree of risk and is highly speculative in nature; mineral resources are not mineral reserves, they do not have demonstrated economic viability, and there is no certainty that they can be upgraded to mineral reserves through continued exploration; few properties that are explored are ultimately developed into producing mines; geological factors; the actual results of current and future exploration; changes in project parameters as plans continue to be evaluated, as well as those factors disclosed in the Company's publicly filed documents.

There can be no assurance that any mineralisation that is discovered will be proven to be economic, or that future required regulatory licensing or approvals will be obtained. However, the Company believes that the assumptions and expectations reflected in the forward-looking information are reasonable. Assumptions have been made regarding, among other things, the Company's ability to carry on its exploration activities, the sufficiency of funding, the timely receipt of required approvals, the price of gold and other precious metals, that the Company will not be affected by adverse political and security-related events, the ability of the Company to operate in a safe, efficient and effective manner and the ability of the Company to obtain further financing as and when required and on reasonable terms. Readers should not place undue reliance on forward-looking information.

Sarama does not undertake to update any forward-looking information, except as required by applicable laws.

SOURCE: Sarama Resources Ltd.



View the original press release on ACCESS Newswire

© 2025 ACCESS Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.